Tag Archives | M Mann

Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia

Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Baeten JM, Babigumira JB, Garrison LP, Stergachis A. Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia. Pharmacoepidemiology and Drug Safety. 2016, Vol 25, Issue 9; 1052-1060.

Read the full article

Read full story · Comments are closed

Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility Analysis

Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Babigumira JB, Garrison Jr LP, Stergachis A. Active surveillance versus spontaneous reporting for first-line antiretroviral medicines in Namibia: A cost-utility analysis. Drug Safety. 2016, Vol. 39, Issue 9; 859-872.

Read the full article

 

Read full story · Comments are closed

Sentinel Site Active Surveillance of the Safety of First-Line Antiretroviral Medicines in Windhoek Central Hospital and Katutura Intermediate Hospital

In the Republic of Namibia, the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program receives funding from the US Government to provide technical guidance for the development and implementation of innovative strategies and programs to strengthen pharmaceutical systems in support of the HIV/AIDS program. SIAPS is collaborating with USAID/Namibia to ensure the availability of quality pharmaceutical products and effective pharmaceutical services to achieve desired health outcomes for the government of the Republic of Namibia.

The Therapeutics Information and Pharmacovigilance Centre (TIPC) is responsible for the promotion of the rational and safe use of medicines in Namibia. Officially launched in 2008 as part of the Ministry of Health and Social Services (MoHSS), it is the official centre for the provision of unbiased therapeutics information and pharmacovigilance services to health care professionals and the general public. The Centre became the 90th full member of the World Health Organization (WHO) Programme for International Drug Monitoring in 2008.

The SIAPS Program in Namibia supports the implementation of initiatives to improve treatment outcomes through strategies that promote pharmacovigilance at the health facility and community levels. Additionally, in collaboration with UW, SIAPS is providing technical guidance towards the implementation of medication risk management strategies at selected referral hospitals in Namibia. In FY12, SIAPS supported the initiation of prospective active surveillance of the safety of antiretroviral medicines at the Windhoek Central Hospital and the Katutura Intermediate Hospital. In FY13, SIAPS continued to provide technical assistance towards the implementation of prospective active surveillance of ARV medicines so that the collected data is managed accurately, and to ensure that the active surveillance system is a long-term and beneficial investment.

Read full story · Comments are closed